Periodic Reporting for period 2 - UniMab (Immune-privileged, immortal, myogenic stem cells for gene therapy of Muscular Dystrophy.)

Duchenne muscular dystrophy (DMD) is a devastating incurable disease, affecting thousands with heavy burden on the health systems. This project combines the development of a safe, “immune-privileged cell” with genetic engineering to correct many dystrophin gene mutations...